Somatic MIWI2 Hinders Direct Lineage Reprogramming From Fibroblast to Hepatocyte

Stem Cells
Xiaojie ShiGuang Yang

Abstract

Remodeling of the gene regulatory network in cells is believed to be a prerequisite for their lineage reprogramming. However, its key regulatory factors are not yet elucidated. In this article, we investigate the role of PIWI proteins and provide evidence that one of them, MIWI2, is elicited during transdifferentiation of fibroblasts into hepatocyte-like cells. In coincidence with the peak expression of MIWI2, we identified the appearance of a unique intermediate epigenetic state characterized by a specific Piwi-interacting RNA (piRNA) profile consisting of 219 novel sequences. Knockout of MIWI2 greatly improved the formation of the induced hepatocytes, whereas overexpression of exogenous MIWI2 completely abolished the stimulated effect. A bioinformatics analysis of piRNA interaction network, followed by experimental validation, revealed the Notch signaling pathway as one of the immediate effectors of MIWI2. Altogether, our results show for the first time that temporal expression of MIWI2 contributes negatively to cell plasticity not only in germline, but also in developed cells, such as mouse fibroblasts. Stem Cells 2019;37:803-812.

References

Mar 10, 2004·The International Journal of Developmental Biology·Katja SeipelVolker Schmid
Jun 6, 2006·Nature·Angélique GirardMichelle A Carmell
Jun 6, 2006·Nature·Alexei AravinThomas Tuschl
Jun 13, 2006·Genes & Development·Shane T GrivnaHaifan Lin
Jul 1, 2006·Science·Vasily V VaginPhillip D Zamore
Sep 15, 2006·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Jan H SchefeHeiko Funke-Kaiser
Oct 13, 2006·Mechanisms of Development·Toshinori HayashiHisato Kondoh
Mar 31, 2007·Developmental Cell·Michelle A CarmellGregory J Hannon
Jul 27, 2007·RNA·Yohei Kirino, Zissimos Mourelatos
Aug 30, 2008·Nature·Qiao ZhouDouglas A Melton
Feb 26, 2009·Cell·Colin D Malone, Gregory J Hannon
Jan 10, 2008·Annual Review of Cell and Developmental Biology·Travis Thomson, Haifan Lin
Jan 29, 2010·Nature·Thomas VierbuchenMarius Wernig
Jan 13, 2011·Bioinformatics·Yi ZhangLe Kang
Jan 22, 2011·Nature Reviews. Molecular Cell Biology·Chris JoplingJuan Carlos Izpisua Belmonte
Nov 8, 2011·Genes & Development·Kenneth S Zaret, Jason S Carroll
Jan 12, 2012·BMC Bioinformatics·David Rosenkranz, Hans Zischler
Jul 31, 2012·Nature Structural & Molecular Biology·Anastassios VourekasZissimos Mourelatos
Jan 19, 2013·Seminars in Reproductive Medicine·Cristina EguizabalJuan Carlos Izpisua Belmonte
Feb 26, 2013·Developmental Cell·Xiao A HuangHaifan Lin
Apr 23, 2013·Cancer Letters·Yuping MeiLi Mao
May 25, 2013·Current Opinion in Genetics & Development·Atsushi Suzuki
Jan 17, 2014·Nature·Robert J RossHaifan Lin
Jun 17, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Francesca RizzoAlessandro Weisz
Feb 7, 2015·Cell Stem Cell·Jun XuHongkui Deng
Mar 10, 2015·Annual Review of Biochemistry·Yuka W IwasakiHaruhiko Siomi
Apr 22, 2015·Journal of Hematology & Oncology·Miguel Moyano, Giovanni Stefani

❮ Previous
Next ❯

Citations

May 31, 2019·Stem Cells·Stuart P Atkinson

❮ Previous
Next ❯

Methods Mentioned

BETA
FACS
AlphaLISA
PCR
transfection
flow cytometry

Software Mentioned

AlphaLISA
proTRAC
FastQC

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.